SHINE Medical Technologies was given a 91-acre parcel on the south side of Janesville for the company’s U.S. medical isotope production facility, the company announced recently. “This transfer represents the…

Promega announced recently that it launched a new tool called Water-Glo System that can be used for monitoring microbial contamination in freshwater, process water, seawater or wastewater samples. According to…

BioForward hosted the first Wisconsin event that collected genomics data, the organization announced recently. According to a release, BioForward partnered with keynote speaker Dr. Chris Mason, Associate Professor of Weill Cornell…

More than two million Americans have been screened for colorectal cancer using Exact Sciences‘ Cologuard, the company announced today. “Cologuard is changing how Americans get screened for colorectal cancer and,…

Exact Sciences recently announced its latest financial report, which showed revenue of $454.5 million and  934,000 completed Cologuard tests during last year, an increase of 71 percent and 64 percent, respectively,…

The majority of people with asthma may be using their inhalers incorrectly. That’s according to research by Propeller Health, in partnership with the University of Colorado School of Medicine and Children’s…

SHINE Medical Technologies and NorthStar Medical Radioisotopes are part of a list of four companies to begin negotiations for potential new cooperative agreement awards on the production of Molybdenum-99 (Mo-99) with the…

Propeller Health is partnering with Orion Corporation, a digital therapeutics company, to connect its Easyhaler line of inhalers for asthma and COPD to Propeller’s digital medicine platform. “This partnership with Orion…

Dianomi Therapeutics, a biohealth company focused on osteoarthritis and pain with technology, has received a $3 million investment from its new partner, Ligand Pharmaceuticals, the company announced recently. According to a…

Invenra and the Wisconsin Alumni Research Foundation have entered into a collaboration to discover and develop a bispecific antibody therapeutic for the treatment of neuroblastoma, the company announced recently. “This…